Gilead Sciences | GILD - Cost Of Sales


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Gilead Sciences

Gilead Sciences reported $1.4B in Cost of Sales for its fiscal quarter ending in March of 2023.


Cost Of Sales Change
AbbVie ABBV:US USD 3.97B 200M
Acorda Therapeutics ACOR:US USD 3.23M 1.33M
Agios Pharmaceuticals AGIO:US USD 554K 141K
ALKERMES ALKS:US USD 58.18M 4.21M
Alnylam Pharmaceuticals ALNY:US USD 54.87M 3.6M
Amgen AMGN:US USD 1.68B 65M
Biogen BIIB:US USD 662.8M 91.9M
BioMarin Pharmaceutical BMRN:US USD 126.55M 741K
Bluebird Bio BLUE:US USD 3.38M 3.36M
Bristol-Myers Squibb BMY:US USD 2.56B 45M
Coherus Biosciences CHRS:US USD 16.87M 2.67M
Eli Lilly LLY:US USD 1.63B 78.6M
Gilead Sciences GILD:US USD 1.4B 5M
GlaxoSmithKline GSK:LN GBP 1.9B 274M
Glaxosmithkline GSK:US GBP 1.9B 274M
Incyte Corp INCY:US USD 51.42M 2.34M
Intercept Pharmaceuticals ICPT:US USD 222K 194K
J&J JNJ:US USD 8.4B 684M
Merck & Co MRK:US USD 3.35B 491M
Moderna Inc MRNA:US USD 792M 1.13B
Neurocrine Biosciences NBIX:US USD 8.5M 800K
Novartis NOVN:VX USD 3.83B 8M
Pfizer PFE:US USD 5.03B 4.8B
PTC Therapeutics PTCT:US USD 14.14M 3.25M
Puma Biotechnology PBYI:US USD 13.22M 3.62M
Regeneron Pharmaceuticals REGN:US USD 457.5M 83.1M
Sarepta Therapeutics SRPT:US USD 35.02M 4.22M
United Therapeutics UTHR:US USD 52.3M 6.5M
Vertex Pharmaceuticals VRTX:US USD 266.9M 16.4M